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ABSTRACT: SuperQuant is a quantitative proteomics data processing
approach that uses complementary fragment ions to identify multiple
coisolated peptides in tandem mass spectra allowing for their
quantiﬁcation. This approach can be applied to any shotgun proteomics
data set acquired with high mass accuracy for quantiﬁcation at the MS1
level. The SuperQuant approach was developed and implemented as a
processing node within the Thermo Proteome Discoverer 2.x. The
performance of the developed approach was tested using dimethyl-
labeled HeLa lysate samples having a ratio between channels of 10(heavy):4(medium):1(light). Peptides were fragmented with
collision-induced dissociation using isolation windows of 1, 2, and 4 Th while recording data both with high-resolution and low-
resolution. The results obtained using SuperQuant were compared to those using the conventional ion trap-based approach (low
mass accuracy MS2 spectra), which is known to achieve high identiﬁcation performance. Compared to the common high-
resolution approach, the SuperQuant approach identiﬁes up to 70% more peptide−spectrum matches (PSMs), 40% more
peptides, and 20% more proteins at the 0.01 FDR level. It identiﬁes more PSMs and peptides than the ion trap-based approach.
Improvements in identiﬁcations resulted in up to 10% more PSMs, 15% more peptides, and 10% more proteins quantiﬁed on the
same raw data. The developed approach does not aﬀect the accuracy of the quantiﬁcation and observed coeﬃcients of variation
between replicates of the same proteins were close to the values typical for other precursor ion-based quantiﬁcation methods.
The raw data is deposited to ProteomeXchange (PXD001907). The developed node is available for testing at https://github.
com/caetera/SuperQuantNode.
Mass spectrometry-based proteomics is the leadingmethod in qualitative and quantitative investigation of
biological systems, and the most commonly used approach is
shotgun proteomics.1 Brieﬂy, proteins are extracted from the
biological matrix of interest (tissue, cell culture, organelle, etc.)
and digested by one or more proteolytic enzymes. The peptide
mixture obtained is separated by HPLC and analyzed by
tandem mass spectrometry (MS/MS). The resulting fragmen-
tation spectra are processed with dedicated software that
accesses protein databases to identify and quantify peptides
present in the sample.
Typical shotgun proteomics experiments address several
thousand proteins and result in tens or even hundreds of
thousands of peptides presenting in the sample.2,3 Common
proteomics methodologies use fractionation before LC-MS/MS
analysis to reduce peptide complexity and obtain the deepest
possible coverage of the proteome.4−6 However, this is labor
intensive, requires a lot of time, and increases the possibility of
introducing experimental errors and loss of sample.6 An
important challenge for shotgun proteomics is the high
frequency of precursor ion coisolation in the MS/MS event.
Progress in increasing the sensitivity and speed of MS
instrumentation allows deeper investigation of peptide
mixtures, thus making this problem increasingly relevant.
Recent studies show that approximately 50% of all
fragmentation spectra suﬀer from coisolation of precursor
ions.3,7−10 Moreover, the recent trend in shotgun proteomics is
to obtain complete or near complete quantitative and
qualitative proteome coverage quickly (e.g., hours) in one
experiment.11−13 Hence, single-shot proteome analysis lowers
operation costs, instrument operation time, and is easier to
apply in an automated, nonattendant way.12 It inevitably leads,
however, to increased complexity of the peptide sample, thus
forcing more precursor ion coisolation events to occur.
Fragmentation spectra originating from coisolated precursor
ions, also referred to as “chimera spectra” or “mixture spectra”,
reduce the chance of the correct identiﬁcation of the target
peptide and hence lower the identiﬁcation success rate by
lowering the conﬁdence score threshold.7
There are several methods for extracting quantitative
information from mass spectrometry data. Most of these aims
to provide relative quantiﬁcation (e.g., observe the change in
the amount of proteins or peptides between diﬀerent states of
the same biological system or between the samples). The
dominant approaches of quantitative proteomics are divided
into two major directions, with measurements of the
abundances in the MS spectrum versus the MS/MS spectrum.
The most widely used methods of MS/MS spectra-based
quantitation are iTRAQ14 and TMT15 isotopic labeling. The
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relative abundances of MS/MS reporter ions are used to derive
peptide abundances. In the chimera spectra, reporter ions from
all precursors will overlap, leading to inaccurate estimation of
abundance ratios between samples. This eﬀect is most
pronounced for ratios close to 1:1. Possible ways to circumvent
this eﬀect include the use of additional MS3 fragmentation16 or
correction coeﬃcients calculated using spiked-in-proteins.17
The MS1 spectrum-based methods use abundances of the
parent ion isotopic envelopes in survey MS1 spectra as a
representative for peptide levels. The most well-known
methods of this type are SILAC18 and dimethyl labeling,19,20
and label-free methods can be assigned to the same category.
This isotopic labeling strategy does not suﬀer from inaccuracy
in reporter ion abundances. Unfortunately, the extensive
coisolation of multiple peptides in the MS/MS event inevitably
results in many unassigned peptide identiﬁcations and
quantiﬁcation of unknown peptide species has limited analytical
value. In the presence of peptide coisolation, several over-
lapping peak envelopes can be observed in the survey MS1
spectrum. Parent mass and ion abundance can be assigned to
each of them, however, only a few proteomic tools can account
for these cases.9 Moreover, most of them are able to identify
and later quantify only one additional peptide after successful
identiﬁcation of the target peptide.21−23
As shown earlier,24,25 the mass relationship between
complementary fragment ions can be used to deconvolute
mixture spectra. Because complementary fragment ions can be
used to derive individual and unique peptide parent masses, this
information can be used to select the corresponding peak
envelope from the parent mass spectrum to obtain individual
quantitative values. In this study, we took advantage of this
possibility and demonstrated how complementary fragment
ions allow assessment of quantitative information in MS1 scans.
The software employing this concept was developed and
thoroughly tested for its applicability to obtain biologically
relevant data using a HeLa cell lysate.
■ MATERIALS AND METHODS
Reagents. If not explicitly stated, all common solutions and
reagents were purchased from Sigma-Aldrich and were of
HPLC grade or proteomics grade (when applicable).
Cell Culture. Human cervix epithelial adenocarcinoma
(HeLa) cells were cultured in 15 cm cell culture dishes in
Dulbecco’s Modiﬁed Eagle Medium (DMEM) with Glutamax
media supplemented with 10% fetal bovine serum (FBS) and
1% penicillin/streptomycin. Cells were harvested at 90%−95%
conﬂuency by scraping them oﬀ the plate followed by
centrifugation. Pellets were stored at −80 °C until further
analysis.
Protein Digestion. Cells were lysed and proteins were on-
ﬁlter digested as previously published.26 Brieﬂy, HeLa cells were
lysed with a solution of 2% (w/v) sodium dodecyl sulfate
(SDS), 20 mmol/L triethylammonium bicarbonate (TEAB),
0.1 mol/L dithiothreitol (DTT), phosphatase (PhosSTOP,
Roche, Switzerland), and protease inhibitors (cOmplete,
Roche, Switzerland). Lysis was enhanced and DNA ﬁlaments
sheared with tip sonication on ice. Protein concentration was
measured using Qubit assay (Thermo Fisher Scientiﬁc, USA).
Proteins were loaded onto spin-ﬁlter units (Vivacon 500, 30000
MWCO; Vivaproducts, USA), and the SDS-containing solution
was washed out using an urea-containing solution (8 mol/L
urea, 20 mmol/L TEAB. Two protein loadings of 75 μL each
(600 μg on ﬁlter) were used, 300 μL of urea solution were used
for washing after each loading followed by two washes with 200
μL of urea, and two washes with 375 μL of 1% (w/v) sodium
deoxycholate (SDC), 20 mmol/L TEAB after both loadings.
Alkylation of the reduced thiol groups was done with 50 mmol/
L iodoacetamide, 1% (w/v) SDC, and 20 mmol/L TEAB (300
μL of solution, followed by two times wash with 300 μL of 1%
(w/v) SDC, 20 mmol/L TEAB), and proteins were digested
overnight with trypsin (1:100) (Promega, USA) in 1% (w/v)
SDC, 20 mmol/L TEAB. Peptides were collected after
centrifugation, and SDC was removed using ethyl acetate and
TFA (0.5% (v/v) ﬁnal concentration).
Dimethyl Labeling. Dimethyl labeling was performed
according to a published protocol.27 Brieﬂy, 25 μg of peptides
per labeling channel were dissolved in 100 μL of 0.1 mol/L
TEAB. The peptide amount was measured by amino acid
analysis (Biocrom 30, Biochrom, UK). Next, 4 μL of 4% (v/v)
solution of CH2O, CD2O, or
13CD2O were added, and the
samples were vortexed. Following, 4 μL of 0.6 mol/L
NaBH3CN or NaBD3CN were added and the mixture was
incubated for 75 min at room temperature. The eﬃciency of
labeling was monitored by HPLC-MS before quenching the
reaction. The reaction was quenched by adding 16 μL of 1%
(v/v) ammonia solution followed by 8 μL of 5% (v/v) formic
acid. Next, the three channels were mixed in a 10:4:1
(light:medium:heavy) ratio. The samples were completely
dried in a SpeedVac and stored at −20 °C until analyzed by
LC-MS.
LC-MS. Peptides were separated using a Dionex (now
Thermo, USA) Ultimate 3000 nanoUPLC system, coupled to a
Thermo Orbitrap Fusion mass spectrometer. Peptides were
focused on the precolumn (PepMap C18 10 cm × 150 μm i.d.,
5 μm; Thermo, USA) and eluted from the analytical column
(PepMap C18 50 cm × 75 μm i.d., 3 μm; Thermo, USA) with
the gradient presented in Table 1. The mass spectrometer was
conﬁgured to continuously fragment peptide precursor ions for
3 s (top speed mode) between each MS1 scan. MS1 spectra
were recorded in the Orbitrap mass analyzer from 400 to 1200
Th, with 120000 resolution at 200 Th, automated gain control
(AGC) target value 5 × 105, maximum accumulation time 60
ms. Ions were isolated using a quadrupole mass ﬁlter with 1, 2,
and 4 Th wide isolation windows and fragmented using
collision-induced dissociation (CID) in the linear ion trap. MS/
MS spectra were acquired with Orbitrap detection with 15000
resolution at 200 Th, AGC target 1 × 104, maximum
accumulation time 40 ms (referenced as OT-OT technique).
For comparison, Orbitrap−ion trap mode (OT-IT technique)
was used. CID spectra were recorded in the linear ion trap
using “Rapid” settings, AGC target value 5 ×103, maximum
accumulation time 35 ms, and 2 Th isolation window.
Proteome Discoverer Nodes Development. An algo-
rithm for identiﬁcation and extraction of coisolated peptide
fragments was implemented in C# (Visual C# 2013, .NET
Framework 4.5.50938) and compiled as a node for Proteome
Discoverer 2.x (ComplementaryFinder node). The core idea of
the algorithm was published previously;24 however, the new
Table 1. HPLC Gradient Used for the Analysisa
time
(min)
0 5 25 205 245 270 285 287 300
B (%) 2 2 5 21 35 99 99 2 2
aA: 0.1% formic acid. B: 80% acetonitrile in 0.1% formic acid.
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version has important improvements. The code was fully
rewritten to accommodate implementation in Proteome
Discoverer and to increase stability and performance.
Implementing ComplementaryFinder into Proteome Discov-
erer allows users to apply a variety of other processing tools and
have the support of more input/output formats. The following
new features were added: relative coisolation window borders,
selective extraction of primary and secondary spectra, exclusion
masses, and secondary mass spectra veriﬁcation by survey MS1
scan. The explanation of the new parameters is presented in the
Results and Discussion. An algorithm for deconvolution of
mass spectra to singly charged fragment spectra was
implemented in a similar manner; details of applied processing
are described in the Results and Discussion. Microsoft Visual
Studio Professional 2013 (v 12.0.30501.00 Update 2) was used
as an integrated development environment. The developed
node is available for testing at https://github.com/caetera/
SuperQuantNode.
Data Analysis. Data analysis was performed using Thermo
Proteome Discoverer 2.0.0.673. Mascot 2.3 was used as the
database search engine. SwissProt database (2014.04) restricted
to Homo sapiens (20340 protein sequences) combined with a
common contaminants database (231 protein sequences) was
used. Search parameters for the OT-OT technique were: parent
ion mass tolerance, 5 ppm; fragment ion mass tolerance, 0.02
Th; ﬁxed modiﬁcations, carbamidomethylated cysteine; variable
modiﬁcations, oxidized methionine and labeled N-terminal and
lysine. For the OT-IT technique, fragment ion mass tolerance
was set to 0.5 Th, while other parameters were the same.
Reversed decoy database was searched separately. For Super-
Quant analysis, all MS2 spectra were processed using home-
built deconvolution node to produce fragmentation spectra
consisting only of singly charged fragments. Next, deconvoluted
spectra were processed with ComplementaryFinder node
before database search. Database search results were evaluated
using Percolator 2.0528 with standard parameters. All peptide−
spectrum matches (PSMs) with q-value <0.01 were grouped
together by the same sequence and theoretical mass and the
highest Percolator SVM score was used as the score for the
group. Qvality 2.0529 was used for the estimation of q-value on
the PSM group level; PSM groups were ﬁltered by q-value
<0.01. Each PSM group gives rise to one peptide. Proteins
related to the ﬁltered peptides were grouped using the
maximum parsimony principle. No FDR ﬁlters were applied
at the protein level. Quantiﬁcation of peptides and proteins was
performed using standard settings provided by Proteome
Discoverer. Quantiﬁcation was based on extracted ion
chromatograms. Allowed mass deviation in consecutive scans,
6 ppm; retention time tolerance of isotopic multiplets, 0.2 min;
minimum signal-to-noise ratio for peaks to be considered for
quantiﬁcation, 1. Mass spectrometric data were deposited to the
ProteomeXchange Consortium (http://proteomecentral.
proteomexchange.org) via the PRIDE30 partner repository
(PXD001907).
■ RESULTS AND DISCUSSION
Identiﬁcation Performance of SuperQuant. The ﬁrst
operation of SuperQuant is to employ complementary ion
information to improve the quality and number of PSMs during
database search and identify cofragmented peptides originating
from diﬀerent precursors. Next, quantitative information for
each PSM is extracted to increase the quantiﬁed coverage of
complex proteomes. To thoroughly test and optimize our
approach, we performed dimethyl labeling of equal amounts of
HeLa cell lysate using light, medium, and heavy versions of the
labeling reagent. Labeled samples were mixed in 10:4:1
(L:M:H) ratio and analyzed together without prefractionation.
Eﬀort was made to balance the peptide elution from the
column by compressing the regions of highly hydrophilic and
more hydrophobic peptides, the latter being usually less
populated than the other regions. The ﬁnal HPLC gradient
proﬁle consisted of three linear gradient regions with diﬀerent
slopes (Table 1): a steep initial gradient was followed by a long
and gentle gradient of 5−21% buﬀer B over 180 min, which was
followed by a sharp increase to 35% buﬀer B.
The width of the isolation window aﬀects the occurrence of
precursor ion coisolation. The mainstream principle in shotgun
proteomics is to shrink the width as much as possible to
minimize the frequency of coisolation. Recently, Hebert et al.11
used a 0.7 Th isolation window for a full yeast proteome
analysis while the instrument itself was shown to be eﬃcient
even with an isolation window of 0.4 Th. However, the
complexity of the sample analyzed in a typical shotgun
experiment is too great to avoid peptide coisolation with any
reasonable isolation window.31 It is now well recognized that
the one spectrum = one peptide assumption should be critically
revisited.8,32 To test the ability of our approach to solve the
coisolation challenge, we analyzed labeled HeLa sample using
isolation windows of 1, 2, and 4 Th (each one in triplicate).
Each run was analyzed using standard and SuperQuant
approaches (see Materials and Methods). With the SuperQuant
approach, fragmentation spectra were deconvoluted to the
singly charged state, and all peaks that could not be assigned to
any charge state according to the isotopic pattern were
transferred to the deconvoluted spectra with charge state 1+.
ComplementaryFinder node (part of the SuperQuant ap-
proach) was applied with the following parameters. The
allowed mass range for coisolated precursors (coisolation
window) was set 0.6 Th wider on the lower border than the
isolation window (e.g., for the isolation window 500−501 Th,
the corresponding range of allowed coisolated masses was
499.4−501 Th). This border selection was applied to
accommodate 2+ ions presented at the lower border of the
isolation window if only the ﬁrst isotopic peak was coisolated.
Expected charge states for coisolated ions were 2+, 3+, and 4+,
which covers typical charge states for tryptic peptides. All
reconstructed (b−y pairs) peptide masses were grouped with a
5 ppm window (e.g., masses having absolute diﬀerences less
than 5 ppm are considered to belong to the same peptide), and
the abundance weighted average (∑j Mj × Ij/∑j Ij, where Mj =
mass, Ij = corresponding abundance) of all masses in the group
was used as the ﬁnal estimation of the peptide mass. Each mass
supported by at least six ions (three complementary ion pairs)
was considered to represent a coisolated peptide. Ion peaks
supporting this mass were used to generate virtual secondary
spectra (extracted). No minimum restrictions were applied to
the number of complementary pairs supporting the targeted
mass. The spectrum corresponding to it was termed “primary
spectrum” and always added to the result. All ions having
absolute mass diﬀerences less than 10 ppm from the masses of
immonium ions formed from 20 common amino acids were
excluded from the list of possible complementary pair
members. Ions that were not satisfying the complementary
rules were added to each resulting spectrum. Finally, peaks
corresponding to complementary pairs were intensiﬁed (the
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abundance of both ions in a pair was increased by the
abundance of the basepeak).
The numbers of PSMs, peptides, and proteins identiﬁed in
labeled HeLa samples are provided in Table 2. For a standard
approach (i.e., with standard processing), the best performance
was obtained using the 1 Th isolation window even though the
abundance of the isolated parent ions might be hampered by
the narrow isolation window. Notably, even with the 1 Th
isolation window, approximately one additional spectrum was
generated for every three recorded spectra, indicating that
coisolation was frequent even at narrow isolation settings. For
wider isolation windows (4 Th), the number of generated
virtual secondary spectra increased, reaching approximately 20
times multiplication in one of the replicates. Such a high
multiplication factor could indicate that each isolated spectrum
was more complex and contained multiple coisolated peptides
or that the data were compromised with many low-quality
secondary spectra generated from noise peaks or random
events. The average number of peaks per spectrum supplied for
ComplementaryFinder node (after deconvolution) was 50, 84,
and 150 peaks for 1, 2, and 4 Th isolation windows,
respectively. The probability of ﬁnding coisolated peptide
purely by chance is proportional to the squared number of
peaks in the spectra; therefore, it was approximately nine times
higher for 4 Th than for 1 Th. This assumption was supported
by the lower success rate (fraction of spectra that have PSM
assigned) observed for 4 Th samples. Overall, the success rates
for all SuperQuant analyses were lower than those for the
standard processing, indicating that the quality of virtual
secondary spectra might be lower. Such a reduction in the
identiﬁcation rate was expected because SuperQuant processing
results in the inclusion of many low-abundance spectra;
however, the overall number of identiﬁed PSMs, peptides,
and proteins was larger. It should be noted that we used high
throughput parameters for MS/MS data acquisition (AGC
target 1 × 104) and, therefore, the typical number of ions
collected to generate the target and secondary product spectra
was small. Most of the ion current in the isolation window was
expected to be determined by the targeted precursor ion, thus,
as a consequence of the AGC target value, ion statistics for
coisolated peptides were poorer than for the targeted peptide.
Two diﬀerent formulas were used to calculate the number of
PSMs, peptides and proteins identiﬁed in the combined
samples of the replicates. Because correct alignment of PSMs
across diﬀerent replicates is diﬃcult to assess, the correspond-
ing results are the sum of those for individual samples (e.g.,
1Th = 1Th-1 + 1Th-2 + 1Th-3). Conversely, it is
straightforward to align the same peptide or protein across all
samples, thus a rollup was performed using the sequence,
including all modiﬁcations, as the unique identiﬁer of peptide
and the full name of the protein as its unique identiﬁer. In
Table 2, the number of identiﬁed proteins and peptides in the
combined samples were less than the sum of each individual
sample; moreover, the relative improvement for the combined
sample was higher than the average improvement for individual
samples, which is typical for data-dependent acquisition.
The bottom of Table 2 contains the number of PSMs,
peptides, and proteins identiﬁed using Orbitrap detection in
survey scans and ion trap detection in MS/MS scans (OT-IT).
The SuperQuant approach could not be applied for this data
because it requires high mass accuracy fragmentation spectra
and hence the corresponding columns are empty. The use of
ion trap detection is recommended for Orbitrap Fusion by the
manufacturer because it allows eﬃcient parallelization of survey
and product ion scans, maximizes the utilization of all
instrument parts, and is shown to deliver the highest
performance.33 Thus, it is important to compare the OT-IT
technique with the SuperQuant approach. Comparison of the
OT-IT against OT-OT technique using standard processing
shows that the former technique has lower success rate. This
observation was expected because ion trap spectra have lower
spectral quality. Despite this lower spectral quality, the numbers
of identiﬁed PSMs, peptides, and proteins are higher than for
the standard processing approach. By contrast, SuperQuant
outperforms the OT-IT technique in identiﬁed PSMs and
peptides for all tested parameters, but the number of identiﬁed
proteins was slightly higher for OT-IT. It is worth mentioning
that the SuperQuant processing results in a higher number of
identiﬁcations and provides on average higher quality spectra
Table 2. Identiﬁed PSMs, Peptides, and Proteins in HeLa 10:4:1 Samplea
MS2 spectra PSMs peptides proteins
sample Std SQ Mult. Std SQ Diﬀ (%) Std SQ Diﬀ (%) Std SQ Diﬀ (%)
1Th-1 139963 182916 1.31 50472 (0.36) 63976 (0.33) +26.76 39207 45156 +15.17 4403 4617 +4.86
1Th-2 140709 176661 1.26 48677 (0.35) 59221 (0.32) +21.66 38421 43424 +13.02 4385 4518 +3.03
1Th-3 140865 211530 1.50 53216 (0.38) 69270 (0.30) +30.17 39855 46506 +16.69 4330 4657 +7.55
1Th 421537 571107 1.35 152365 (0.36) 192467 (0.32) +26.32 52982 62574 +18.10 5249 5466 +4.13
2Th-1 140550 311704 2.22 48872 (0.35) 73788 (0.19) +50.98 37917 47984 +26.55 4355 4792 +10.03
2Th-2 141292 303560 2.15 48072 (0.34) 70351 (0.19) +46.35 37432 46880 +25.24 4407 4788 +8.65
2Th-3 141453 448494 3.17 50893 (0.36) 78628 (0.13) +54.50 38165 48280 +26.50 4309 4867 +12.95
2Th 423295 1063758 2.51 147837 (0.35) 222767 (0.16) +50.68 49917 67324 +34.87 5129 5679 +10.72
4Th-1 140898 1367412 9.70 41268 (0.29) 73593 (0.05) +78.33 32256 41035 +27.22 4008 4636 +15.67
4Th-2 141290 2304728 16.31 42195 (0.30) 72994 (0.03) +72.99 32315 38953 +20.54 3940 4712 +19.59
4Th-3 141218 2804985 19.86 42470 (0.30) 71993 (0.03) +69.51 31831 37243 +17.00 3871 4647 +20.05
4Th 423406 6477125 15.30 125933 (0.30) 218580 (0.03) +73.57 41995 60309 +43.61 4592 5534 +20.51
IT-1 201113 N/A N/A 56391 (0.28) N/A N/A 42576 N/A N/A 5035 N/A N/A
IT-2 201365 N/A N/A 57575 (0.29) N/A N/A 41490 N/A N/A 4805 N/A N/A
IT-3 198973 N/A N/A 56963 (0.29) N/A N/A 40744 N/A N/A 4782 N/A N/A
IT 601451 N/A N/A 170929 (0.28) N/A N/A 55967 N/A N/A 5762 N/A N/A
aNumber in parentheses designates the success rate (PSMs/MS2 Spectra); Std, standard approach; SQ, SuperQuant approach; Mult., MS2 spectra in
SQ/MS2 spectra in Std; Diﬀ, relative diﬀerence between standard and SuperQuant.
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(e.g., better mass accuracy, resolution, signal-to-noise ratio,
etc.). Thus, by using SuperQuant, one can obtain better
analytical performance (measured as the number of identiﬁed
PSMs and peptides) than for the OT-IT technique without
compromising resulting mass spectral quality.
Receiver Operating Characteristic (ROC) Analysis. The
performance of the SuperQuant approach is illustrated by the
ROC-type plots depicted in Figure 1. The number of identiﬁed
peptides or PSMs is plotted as a function of q-value (only q-
values less than 0.06 are shown because this region is the most
important for practical applications). q-Values were estimated
by Percolator for PSM and by Qvality for peptide
identiﬁcations.
Overall, the SuperQuant approach identiﬁes many more
peptides and PSMs at all signiﬁcance levels. For PSMs, the
surplus is growing for wider isolation windows because the
number of identiﬁcations is slightly lower for standard data
processing while the number of identiﬁcations for SuperQuant
data is increasing. The extent of identiﬁed unique peptides, as
opposed to PSMs, is more important for the eﬃcient
characterization of the sample. In this regard, the observed
performance for the SuperQuant approach was still favorable,
although to a lesser extent, indicating the redundancy in
identiﬁed PSMs. The most striking diﬀerence was observed for
the 4 Th isolation window, where approximately two times
more PSMs resulted only in 15% more unique peptide
identiﬁcations (q-value = 0.01). On the basis of both the
PSM- and peptide-level performance, we concluded that the
optimal isolation window for SuperQuant was 2 Th.
Quantiﬁcation Performance of SuperQuant. Next, we
assessed the capability of the SuperQuant approach to extend
the depth of the quantitative proteome. Table 3 summarizes
PSMs, peptides, and proteins quantiﬁed in the labeled HeLa
sample. PSM, peptide, or protein was considered successfully
quantiﬁed if a minimum two of three possible channels were
present in the MS1 spectrum. Number of quantiﬁcations was
usually higher using SuperQuant than when the standard
approach was used. This was found even though the ratio of
quantiﬁable peptides was lower in SuperQuant. This can be
explained because some of the additional identiﬁed peptides
had low abundance or the isotopic cluster overlapped with
those of other ions present in the isolation window. Results for
the combined replicate samples were calculated in the same
manner as before: the number of PSMs is the sum of PSMs in
individual samples, and for peptides and proteins the proper
rollup is reported. The relative improvement for the combined
samples was higher than the average improvement of individual
samples, and could be opposite in direction (e.g., peptides 4
Th), indicating more complete sampling of corresponding
spectra features with the SuperQuant approach.
Best performance was achieved with the 2 Th isolation
window, resulting in approximately 10% more quantiﬁed PSMs,
15% more quantiﬁed peptides, and 7% more quantiﬁed
proteins. The quantiﬁcation ratio among quantiﬁed and
identiﬁed PSMs, peptides, and proteins was approximately
constant for the standard approach. It increased from PSMs to
peptides and to proteins, ≈40%, ≈50%, and ≈60%, respectively,
but remained relatively constant for any isolation window. For
SuperQuant, the quantiﬁcation ratio decreased with larger
isolation windows and was generally lower than for the
standard processing, however, the diﬀerence was of little
consequence at the protein level.
Figure 1. ROC-type curves for HeLa 10:4:1 sample. Data of all replicates with the same isolation window are merged.
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Comparison of the results from OT-OT and OT-IT analysis
showed a tendency similar to that observed for identiﬁcations
alone. After SuperQuant processing, the number of quantiﬁed
PSMs and peptides was greater than that found for the OT-IT
technique using 1 Th and 2 Th isolation windows; however, at
4 Th, these numbers were lower. Ion trap-based analysis was
Table 3. Quantiﬁed PSMs, Peptides, and Proteins in HeLa 10:4:1 Samplea
PSMs quantiﬁed PSMs quantiﬁcation ratio
sample Std SQ Std SQ Diﬀ (%) Std (%) SQ (%)
1Th-1 50802 65077 19501 20899 +7.17 38.39 32.11
1Th-2 49242 60287 19039 20316 +6.71 38.66 33.70
1Th-3 53541 70382 20030 21439 +7.03 37.41 30.46
1Th 153585 195746 58570 62654 +6.97 38.14 32.01
2Th-1 48948 74231 18971 21193 +11.71 38.76 28.55
2Th-2 48364 71192 18620 20631 +10.80 38.50 28.98
2Th-3 50971 78863 19123 20906 +9.32 37.52 26.51
2Th 148283 224286 56714 62730 +10.61 38.25 27.97
4Th-1 43029 70775 16791 17623 +4.96 39.02 24.90
4Th-2 43889 68554 16820 16300 −3.09 38.32 23.78
4Th-3 44094 65784 16726 15396 −7.95 37.93 23.40
4Th 131012 205113 50337 49319 −2.02 38.42 24.04
IT-1 56391 N/A 19916 N/A N/A 35.32 N/A
IT-2 57575 N/A 19578 N/A N/A 34.00 N/A
IT-3 56963 N/A 18905 N/A N/A 33.19 N/A
IT 170929 N/A 58399 N/A N/A 34.17 N/A
peptides quantiﬁed peptides quantiﬁcation ratio
sample Std SQ Std SQ Diﬀ (%) Std (%) SQ (%)
1Th-1 39207 45156 16120 17158 +6.44 41.12 38.00
1Th-2 38421 43424 15927 16899 +6.10 41.45 38.92
1Th-3 39855 46506 16113 17102 +6.14 40.43 36.77
1Th 52982 62574 25695 28054 +9.18 48.50 44.83
2Th-1 37917 47984 15698 17169 +9.37 41.40 35.78
2Th-2 37432 46880 15432 16820 +8.99 41.23 35.88
2Th-3 38165 48280 15365 16536 +7.62 40.26 34.25
2Th 49917 67324 24534 28237 +15.09 49.15 41.94
4Th-1 32256 41035 13934 14063 +0.93 43.20 34.27
4Th-2 32315 38953 13807 12851 −6.92 42.73 32.99
4Th-3 31831 37243 13431 11908 −11.34 42.19 31.97
4Th 41995 60309 21436 23431 +9.31 51.04 38.85
IT-1 42576 N/A 16826 N/A N/A 39.52 N/A
IT-2 41490 N/A 15983 N/A N/A 38.52 N/A
IT-3 40744 N/A 15536 N/A N/A 38.13 N/A
IT 55967 N/A 26428 N/A N/A 47.22 N/A
proteins quantiﬁed proteins quantiﬁcation ratio
sample Std SQ Std SQ Diﬀ (%) Std (%) SQ (%)
1Th-1 4403 4617 2537 2612 +2.96 57.62 56.57
1Th-2 4385 4518 2558 2637 +3.09 58.34 58.37
1Th-3 4330 4657 2529 2595 +2.61 58.41 55.72
1Th 5249 5466 3107 3215 +3.48 59.19 58.82
2Th-1 4355 4792 2494 2606 +4.49 57.27 54.38
2Th-2 4407 4788 2496 2605 +4.37 56.64 54.41
2Th-3 4309 4867 2453 2583 +5.30 56.93 53.07
2Th 5129 5679 3041 3260 +7.20 59.29 57.40
4Th-1 4008 4636 2376 2502 +5.30 59.28 53.97
4Th-2 3940 4712 2313 2428 +4.97 58.71 51.53
4Th-3 3871 4647 2243 2299 +2.50 57.94 49.47
4Th 4592 5534 2836 3138 +10.65 61.76 56.70
IT-1 5035 N/A 2779 N/A N/A 55.19 N/A
IT-2 4805 N/A 2657 N/A N/A 55.30 N/A
IT-3 4782 N/A 2617 N/A N/A 54.73 N/A
IT 5762 N/A 3319 N/A N/A 57.60 N/A
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superior to the SuperQuant approach in terms of identiﬁed
proteins, but the diﬀerence was marginal.
Next, we compared the accuracy of quantiﬁcation using
either the standard or the SuperQuant approach. Because the
HeLa sample was constructed to have a speciﬁc ratio between
channels (10:4:1), we determined whether the expected ratios
were observed in our data set. Figure 2 displays the
quantiﬁcation ratio reported for individual peptides in all nine
samples (replicates merged). Because one should expect the
ratios to be 1:10 for the heavy−light pair and 1:4 for the
medium−light pair, all values that were 3-fold higher or lower
than the expected values were removed from the analysis as
outliers.
As displayed in Figure 2, the values of the experimental
channel ratios were close to those expected in all samples. The
standard deviation was smaller compared to the mean value for
medium−light ratios than for heavy−light ratios. The mean
value for heavy−light was lower than the expected value in all
cases; however, it was within ±1 standard deviation from the
mean. This observed result can be due to the fact that the
sampling ratio 1:10 (heavy−light) was more prone to some
inevitable technical errors (e.g., pipetting errors) than the 4:10
(medium−light). By comparing the corresponding ratio
distributions for SuperQuant and standard processing, no
important diﬀerences were found. The standard deviation was
always slightly higher for the SuperQuant approach. This
observation can be explained by the possible increase in low
abundance PSMs quantiﬁed by SuperQuant. The distribution
of observed ratio as a function of abundance for standard and
SuperQuant processing are depicted in Supporting Information
Figures 1 and 2, respectively. The results showed that no bias in
the estimation of sample peptide abundances was introduced by
using the SuperQuant approach.
For further testing, we calculated the coeﬃcient of variation
(CV) between replicate quantitations of proteins by the
standard and the SuperQuant approaches. The data are
presented in Table 4. CVs between 10% and 20% are typical
values reported for parent ion-based quantitation meth-
ods,34−36 thus median CVs observed for both approaches
were within the expected magnitude. SuperQuant CVs were
normally larger than those for the standard approach, which is
not surprising because SuperQuant allows deeper access to the
proteome and hence includes more low-abundance PSMs. The
diﬀerence was around 0.5−2.0% for the medium−light channel
and 1.0−4.0% for the heavy−light channel. The lower CVs
observed for the medium−light channel compared to the
heavy−light channel (∼6% vs ∼13%) could be explained by a
larger average magnitude of the measurements in the medium−
light channel.
Because the ultimate goal of any quantitative proteomics
experiment is to collect reliable and accurate information on
diﬀerentially regulated proteins, we investigated quantiﬁcation
performance on the protein level (Table 5).
Table 5 shows that the SuperQuant processing produced
more unique peptides per protein at every isolation window.
The maximal gain in the number of identiﬁed unique peptides
was observed for 2 Th isolation window and allowed about 0.8
additional unique peptides per protein on average. The
signiﬁcance of the observed diﬀerences was estimated using a
permutation test with 10000 simulations. The expected values
for mean and standard deviation of the diﬀerence are shown in
Table 5. Two-tailed test p-values were below the limit for
Figure 2. Ratio between the abundances of diﬀerentially labeled versions of the same peptide for the HeLa 10:4:1 sample. All abundances were
normalized to the value of the light channel. The bar height corresponds to the mean value, while whiskers correspond to the standard deviations
with their numerical values displayed. Expected ratios (1:10 for heavy/light, 4:10 for medium/light) are shown by dashed lines. Values that diﬀered
more than 3-fold from the expected value were considered outliers and removed from the analysis. Replicates were merged.
Table 4. Median Coeﬃcient of Variation of Protein
Quantitation between Replicatesa
heavy−light ratio medium−light ratio
sample Std (%) SQ (%) Std (%) SQ (%)
1 Th 12.99 13.91 6.01 6.47
2 Th 13.07 15.65 5.93 6.65
4 Th 12.91 17.29 5.57 7.65
aStd, standard approach; SQ, SuperQuant approach.
Table 5. Identiﬁed Unique Peptides per Protein for Standard
and SuperQuant Approachesa
average number of unique
peptides per protein permutation test
isolation
width Std SQ diﬀerence μ σ p-value
1 Th 6.00 6.54 0.54 0.00 0.12 4.84 × 10−6
2 Th 5.80 6.61 0.81 0.00 0.12 2.31 × 10−12
4 Th 5.44 5.76 0.31 0.00 0.11 3.26 × 10−3
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statistical signiﬁcance. Improvement in the number of unique
peptides per protein leads to greater reliability for the
identiﬁcation and quantiﬁcation of proteins.
■ CONCLUSIONS
SuperQuant is a data processing approach for shotgun
proteomics data. It employs complementary fragment ions to
deconvolute coisolated ion species following their quantiﬁca-
tion. The approach was tested using dimethyl-labeled HeLa
lysate samples having a constructed ratio between channels
(10:4:1, H:M:L). SuperQuant provided reliable qualitative and
quantitative information on the sample and performed better
than the conventional data processing approach at the same
signiﬁcance level. At its best, this approach resulted in 70%
more PSM that translated into 40% more unique peptide and
20% more protein identiﬁcations compared to standard
processing of the same data. Moreover, the number of
identiﬁcations was higher than that found with the OT-IT
technique and the quality of the fragmentation data was better.
The observed CVs between proteins among the replicates were
close to the values reported for other precursor ion-based
quantiﬁcation methods. This veriﬁes the reliability and
applicability of results obtained using the SuperQuant data
processing approach. Thus, SuperQuant allows deeper coverage
and quantiﬁcation of the proteome and may reveal new
potentially relevant biological information. The primary
beneﬁts of SuperQuant are (1) the laborious and time-
consuming prefractionation steps can be avoided without
compromising the depth of the analysis, thus saving time and
materials necessary for the analysis, (2) the approach can be
applied to previously acquired data, adding new information to
it, and (3) the researchers can use their instruments more
eﬃciently because the amounts and quality of the data are
higher than that obtained with commonly used approaches.
The results indicated that even with the narrowest isolation
window tested (1 Th), approximately one in three spectra
showed signs of cofragmentation and, on average, 14 additional
spectra were generated per recorded spectrum with the 4 Th
isolation window. The widest isolation window tested (4 Th)
demonstrated the limitations of the presented software. The
number of virtual spectra generated was large, and the
identiﬁcation rate decreased. Better suppression of noise in
the input spectra or more sophisticated ways to validate
coisolated masses could be beneﬁcial for the wider isolation
windows. We suggest using 2 Th as the best balance between
data complexity and results obtained. There is no limitation to
the use of the software with higher-energy collisional
dissociation (HCD) fragmentation spectra, however, it is
expected that it will be most eﬃcient with CID because CID
spectra contain more complementary ion pairs.37 When
SuperQuant workﬂow was applied to HCD fragmentation
data, recorded with a 2 Th isolation window (using acquisition
parameters identical to the OT-OT technique, except for the
gradient length of 2 h), the gain in the number of PSMs,
peptides, and proteins was 32%, 12%, and 6%, respectively.
Despite the fact that with shorter gradient the number of
coisolated precursors is expected to be higher, the improvement
was about two times less than for CID data, however,
SuperQuant workﬂow is clearly applicable for HCD data as
well. Finally, correctly accounting for possible precursor ion
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